Islet autoantibodies in the prediction of diabetes in school children

Diabetes Research and Clinical Practice

Volumn 51, Issue 1, 2001, Pages 51-57

  Samuelsson, U U ^a   Sundkvist, G G ^b   Borg, H H ^b   Fernlund, P P ^b   Ludvigsson, J J ^a  

^a LINKÖPING UNIVERSITY   (Sweden)

^b LUND UNIVERSITY   (Sweden)

Author keywords

Autoantibodies; Prediction; Schoolchildren; Type 1 diabetes

Indexed keywords

AUTOANTIBODY; GLUTAMATE DECARBOXYLASE; GLUTAMATE DECARBOXYLASE 65 ANTIBODY; IA2 AB ANTIBODY; PANCREAS ISLET CELL ANTIBODY; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; ARTICLE; CONTROLLED STUDY; DISEASE PREDISPOSITION; FEMALE; FOLLOW UP; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; PREDICTION AND FORECASTING; RISK ASSESSMENT; RISK FACTOR; SCHOOL CHILD; SCREENING;

ADOLESCENT; AUTOANTIBODIES; CHILD; DIABETES MELLITUS, TYPE 1; FEMALE; GLUTAMATE DECARBOXYLASE; HUMANS; ISLETS OF LANGERHANS; MALE; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; REGISTRIES; RISK FACTORS; SWEDEN;

EID: 0035196395     PISSN: 01688227     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8227(00)00199-6     Document Type: Article

References (30)

1. Predicting Type 1 diabetes
2. A prospective study of the development of diabetes in relatives of patients with insulin-dependent diabetes
3. Can we really predict IDDM
4. The design of trials for prevention of IDDM
5. The epidemiology of diabetes in Swedish children 0-14 years - A 6-year prospective study
6. Familial risk of Type 1 diabetes in European children
7. Differences in risk of insulin-dependent diabetes in offspring of diabetic mothers and diabetic fathers
8. Islet cell and other organ-specific autoantibodies in all children developing Type 1 (insulin-dependent) diabetes mellitus in Sweden during 1 year and in matched control children
9. Can islet cell antibodies predict IDDM in the general population
10. Islet cell antibodies predict insulin-dependent diabetes in United States schoolchildren as powerfully as in unaffected relatives
11. Islet cell antibodies (ICA), insulin autoantibodies (IAA), islet cell surface antibodies (ICSA) and C-peptide in 1031 schoolchildren in a population with a high background incidence of IDDM
12. Incidence of Type 1 (insulin-dependent) diabetes mellitus in Catalonia Spain
13. Incidence of childhood diabetes mellitus in Austria 1979-84
14. Patient administrative system as a tool to validate the ascertaininent in the diabetes incidence study in Sweden (DISS)
15. Prolonged incubation in the two colour immuno fluorescence test increases the prevalence and titres of islet cell antibodies in Type 1 diabetes (insulin-dependent) diabetes mellitus
16. 35S]GAD 65-ligand binding assay
17. Protein tyrosinephosphatase-like protein IA2-antibodies plus glutamic acid decarboxylase 65 antibodies (GADA) indicates autoinimunity as frequently as islet cell antibodies assay in children with recently diagnosed diabetes mellitus
18. Islet cell antibodies are less predictive of IDDM among unaffected children in the general population than in sibs of children with diabetes
19. Value of antibodies to GAD65 combined with islet cell cytoplasmic antibodies for predicting IDDM in a childhood population
20. Relationship of β-cell function and autoantibodies to progression and nonprogression of subclinical Type 1 diabetes
21. Effects of insulin administration in a group of high-risk, non-diabetic, first degree relatives of Type 1 diabetic patients: An open pilot trial
22. Glutamic acid decarboxylase antibodies in screening for autoimmune diabetes: Influence of comorbidity, age, sex on specificity and threshold values
23. GADIA2-combi determination as first-line screening for improved prediction of Type 1 diabetes in relatives
24. Prediction of insulin-dependent diabetes mellitus in siblings of children with diabetes
25. Two-step islet autoantibody screening for risk assessment of Type 1 diabetes in relatives
26. Parameters associated with residual insulin secretion during first year of disease in children and adolescents with Type 1 diabetes mellitus
27. Antibodies to glutamic acid decarboxylase as predictors of insulin-dependent diabetes mellitus before clinical onset of disease
28. Islet autoimmunity in infants with Type 1 diabetic relative is common but is frequently restricted to one autoantibody
29. Prediction of IDDM in the general population. Strategies based on combinations of autoantibody markers
30. Combined use of autoantibodies (IA-2 autoantibody, GAD autoantibody, insulin autoantibody, cytoplasmic islet cell antibodies) in Type 1 diabetes